Psychemedics Stock Alpha and Beta Analysis

PMD Stock  USD 2.34  0.01  0.43%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Psychemedics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Psychemedics over a specified time horizon. Remember, high Psychemedics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Psychemedics' market risk premium analysis include:
Beta
0.11
Alpha
0.025
Risk
0.65
Sharpe Ratio
0.0348
Expected Return
0.0225
Please note that although Psychemedics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Psychemedics did 0.03  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Psychemedics stock's relative risk over its benchmark. Psychemedics has a beta of 0.11  . As returns on the market increase, Psychemedics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Psychemedics is expected to be smaller as well. At present, Psychemedics' Tangible Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 44.4 M, whereas Price Book Value Ratio is forecasted to decline to 2.42.

Enterprise Value

44.4 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Psychemedics Backtesting, Psychemedics Valuation, Psychemedics Correlation, Psychemedics Hype Analysis, Psychemedics Volatility, Psychemedics History and analyze Psychemedics Performance.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.

Psychemedics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Psychemedics market risk premium is the additional return an investor will receive from holding Psychemedics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Psychemedics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Psychemedics' performance over market.
α0.03   β0.11

Psychemedics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Psychemedics' Buy-and-hold return. Our buy-and-hold chart shows how Psychemedics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Psychemedics Market Price Analysis

Market price analysis indicators help investors to evaluate how Psychemedics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Psychemedics shares will generate the highest return on investment. By understating and applying Psychemedics stock market price indicators, traders can identify Psychemedics position entry and exit signals to maximize returns.

Psychemedics Return and Market Media

The median price of Psychemedics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 2.32 with a coefficient of variation of 0.87. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 2.32, and mean deviation of 0.02. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Deep Dive Podcast Is it a problem when able-bodied people use PMAs
09/05/2024
2
PMD Device Solutions RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality
09/17/2024
3
Psychemedics Releases First-Ever Education Insights Report Uncovering Drug Trends in Educational Institutions Through Hair Testing
09/26/2024
4
Acquisition by Kamin Peter of 627 shares of Psychemedics at 6.52 subject to Rule 16b-3
09/30/2024
5
PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion
10/07/2024
6
Bulletin from the Extraordinary General Meeting in PMD Device Solutions AB
10/29/2024
7
Psychemedics Third Quarter 2024 Earnings US0.091 loss per share
11/15/2024
8
PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report
11/20/2024

About Psychemedics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Psychemedics or other stocks. Alpha measures the amount that position in Psychemedics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0071620.0430.0470.0346
Price To Sales Ratio1.561.090.770.73

Psychemedics Upcoming Company Events

As portrayed in its financial statements, the presentation of Psychemedics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Psychemedics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Psychemedics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Psychemedics. Please utilize our Beneish M Score to check the likelihood of Psychemedics' management manipulating its earnings.
19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Psychemedics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports:
Check out Psychemedics Backtesting, Psychemedics Valuation, Psychemedics Correlation, Psychemedics Hype Analysis, Psychemedics Volatility, Psychemedics History and analyze Psychemedics Performance.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Psychemedics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Psychemedics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Psychemedics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...